Publications by authors named "William Tew"

Claim this Profile
A
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer.
Sara Moufarrij, Claire F Friedman, Samuel Freeman, Hunter Green, Nadeem R Abu-Rustum, William Tew

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.
William Dale, Heidi D Klepin, Grant R Williams, Shabbir M H Alibhai, Cristiane Bergerot, William P Tew

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASCO neoadjuvant chemotherapy in ovarian cancer guideline: A SGO endorsement.
Jamie Lesnock, Stéphanie Gaillard, William P Tew

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, Sarah Kane, Qin Zhou, William P Tew

Gynecol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Clinical Insights.
William P Tew, Christina Lacchetti, Stéphanie Gaillard

JCO Oncol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.
Angela K Green, Qin Zhou, Alexia Iasonos, William A Zammarrelli, Britta Weigelt, William Tew

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding frailty and the role of patient-centered care for older adults with gynecologic cancer.
Stephanie Cham, Amanika Kumar, Louise C Walter, Stuart Lichtman, William P Tew

Gynecol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.
Paul Johannet, Matthew Flint, M Herman Chui, Jason Konner, Claire Friedman, William P Tew

Gynecol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.
Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, William A Cliby, Mitchell I Edelson, William P Tew

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer.
Stephen Graves, Mackenzie W Sullivan, Anusha Adkoli, Qin Zhou, Alexia Iasonos, William Tew

Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14.
Jubilee Brown, Austin Miller, Laura L Holman, Floor Backes, Christa Nagel, William P Tew

Gynecol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular resection and reconstruction in recurrent granulosa cell tumor.
Lindsey Finch, Sharif Ellozy, Jaspreet Sandhu, Tulsi Patel, William P Tew

Gynecol Oncol Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.
Mina S Sedrak, Can-Lan Sun, Marie Bae, Rachel A Freedman, Allison Magnuson, William P Tew

J Cancer Surviv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Omali Pitiyarachchi, Peter J Ansell, Robert L Coleman, Minh H Dinh, Laura Holman, William Tew, Krishnansu S Tewari

Gynecol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Sarah Ehmann, Clarissa Lam, Qin Zhou, Alexia Iasonos, Rachel N Grisham, William P Tew

Gynecol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, Tara Soumerai, Aliya Holland, William P Tew

Nat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Tiffany Y Sia, Vivian Wan, Michael Finlan, Qin C Zhou, Alexia Iasonos, William P Tew

Int J Gynecol Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
Jingran Ji, Marie Bae, Can-Lan Sun, Tanya M Wildes, Rachel A Freedman, William P Tew

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top advances of the year: Ovarian cancer.
Melissa A Lumish, Elise C Kohn, William P Tew

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.
Thomas Boerner, Clarissa Lam, Derman Basaran, Ying L Liu, Rachel N Grisham, William P Tew

Int J Gynecol Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.
William Dale, Heidi D Klepin, Grant R Williams, Shabbir M H Alibhai, Cristiane Bergerot, William P Tew

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.
Tiffany Y Sia, Anna Maio, Yelena M Kemel, Kanika S Arora, Sushmita B Gordhandas, William P Tew

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Tiffany Y Sia, William P Tew, Christopher Purdy, Dennis S Chi, Andrew W Menzin, Krishnansu S Tewari

Gynecol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data.
Michael Friedlander, Yeh Chen Lee, William P Tew

Am Soc Clin Oncol Educ Book· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Beryl L Manning-Geist, Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H Kim, William P Tew

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis